source
- GSK completes $10.6 billion acquisition of Nuvalent, the largest in its historyGSK announced it has completed a $10.6 billion purchase of Nuvalent, marking the biggest deal the company has ever undertaken. The transaction was disclosed on Tuesday and values Nuvalent at $124…
- FDA clears Dexcom's Stelo as first OTC continuous glucose monitor for childrenThe U.S. Food and Drug Administration cleared Dexcom's Stelo Glucose Biosensor System for over-the-counter use in children two years of age and older who do not use insulin. This is the first OTC…